Trade ALEC anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Alector, Inc. (ALEC) is trading at US$2.37, down 1.05% today as of Aug 28, 12:19 EDT. The company has a market capitalisation of US$263.51M. Over the past 52 weeks, ALEC has traded between US$1.09 and US$3.40. On Syfe you can trade ALEC with $0 commission and add it to your watchlist.
| Previous close | US$2.39 |
|---|---|
| Market cap | US$263.51M |
| 52-week range | US$1.09 – US$3.40 |
| Volume | 706.68K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Alector, Inc.
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
Year: 2019
Alector Shares Rise After Cantor Fitzgerald Upgrade
Apr 15, 6:53 PM · MT Newswires
Cantor Fitzgerald Upgrades Alector to Overweight From Neutral
Apr 15, 11:27 AM · MT Newswires
Alector Files $400 Million Mixed Shelf
Mar 12, 9:44 PM · MT Newswires
Alector Shares Rise After BTIG Upgrade
Mar 10, 6:40 PM · MT Newswires
BTIG Upgrades Alector to Buy From Neutral, Price Target is $6
Mar 10, 9:59 AM · MT Newswires
Alector, Inc. (ALEC) stock is trading at US$2.37, -1.05% from the previous close of US$2.39.
The market cap for Alector, Inc. (ALEC) stock is approximately US$263.51M.
The 52-week high for Alector, Inc. (ALEC) stock is US$3.40.
The 52-week low for Alector, Inc. (ALEC) stock is US$1.09.
Alector, Inc. (ALEC) does not currently pay a dividend.
Stay on top of ALEC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
